Tools

LEADER 02263cam 2200517 a 4500

001 ocm37182273;

003 OCoLC;

005 20050802143902.0;

007 he bmb024bbca;

008 970624s1995 dcua bb f000 0 eng c;

037 a| 155572b| GAO (202) 512-6000 (Voice); (202) 512-6061 (Fax); (202) 512-2537 (TDD)f| paper copy;

042 a| pcc;

043 a| n-us---;

049 a| ERE$;

074 a| 0546-D (MF);

074 a| 0546-D (online);

086 0 a| GA 1.13:PEMD-96-1;

088 a| GAO/PEMD-96-1;

088 a| B-266023;

110 1 a| United States.b| General Accounting Office=| ^A1924;

245 10 a| FDA drug approval :b| review time has decreased in recent years : report to congressional requesters.;

246 30 a| Review time has decreased in recent years;

260 a| Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548) :b| U.S. General Accounting Office,c| [1995];

300 a| 44 p. :b| ill. ;c| 28 cm.;

336 a| textb| txt2| rdacontent;

337 a| microformb| h2| rdamedia;

338 a| microficheb| he2| rdacarrier;

500 a| Cover title.;

500 a| Distributed to depository libraries in microfiche.;

500 a| Shipping list no.: 97-0398-M.;

530 a| Also available via Internet from the GPO Access web site. Address as of 7/23/03: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:pe96001.pdf; current access is available via PURL.;

500 a| "October 1995.";

504 a| Includes bibliographical references.;

500 a| "GAO/PEMD-96-1.";

500 a| "B-266023"--P. 1.;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

650 0 a| Drugsz| United Statesx| Testing.=| ^A1001107;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

776 1 t| FDA drug approval : review time has decreased in recent yearsh| 44 p.w| (OCoLC)33476690;

856 41 u| https://purl.fdlp.gov/GPO/LPS33624;

949 a| GA 1.13:PEMD-96-1w| sudoch| joyner32;

596 a| 1;

998 a| 690413;

999 a| GA 1.13:PEMD-96-1w| SUDOCc| 1i| MQ1299557d| 8/6/2007l| JDOMIm| JOYNERr| Ys| Yt| JDOFMIu| 1/23/1988x| MICROFORMz| JFEDDOCSo| .STAFF. 0;

FDA drug approval : review time has decreased in recent years : report to congressional requesters.

Author/creator	United States
Format	Microform
Publication Info	Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548) : U.S. General Accounting Office, [1995]
Description	44 p. : ill. ; 28 cm.
Supplemental Content	https://purl.fdlp.gov/GPO/LPS33624
Subjects	United States. Food and Drug Administration. Drugs--United States. --Testing.

Portion of title	Review time has decreased in recent years
General note	Cover title.
General note	Distributed to depository libraries in microfiche.
General note	Shipping list no.: 97-0398-M.
General note	"October 1995."
General note	"GAO/PEMD-96-1."
General note	"B-266023"--P. 1.
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Other forms	Also available via Internet from the GPO Access web site. Address as of 7/23/03: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:pe96001.pdf; current access is available via PURL.
Reproduction note	Microfiche. [Washington, D.C.] : U.S. General Accounting Office, [1996?] 1 microfiche : negative.
Technical rpt number	GAO/PEMD-96-1
Technical rpt number	B-266023
GPO item number	0546-D (MF)
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:PEMD-96-1
Stock number	155572 GAO (202) 512-6000 (Voice); (202) 512-6061 (Fax); (202) 512-2537 (TDD) paper copy

FDA drug approval : review time has decreased in recent years : report to congressional requesters.

Click here for more information about this title